rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

Viread

Subscribe via RSS
Rediff.com  »  News  »   Viread

  News for Viread

  • Business

Cipla may sue US-based AIDS body

 Leading drug maker Cipla has got into a spat, with the US-based non-government organisation AIDS Healthcare Foundation accusing the company of selling key AIDS drug Viraday in India at a high......

Roche's Hepatitis C drug patent challenged

 Swiss pharmaceutical major Hoffmann-La Roche's patents rights over Hepatitis C drug Pegasys has been challenged by public interest groups at the Indian Patent Office. This is the second post-grant......

Ranbaxy, US co tie up for HIV drug

 Ranbaxy Laboratories Ltdsaid on Monday it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing and marketing of Active Pharmaceutical Ingredientand......

Strides Arcolab ties up with US co for HIV drugs

 Strides Arcolab Ltd has signed an agreement with US-based bio-pharmaceutical company, Gilead Sciences, for manufacturing and distributing generic versions of anti-HIV drugs Truvada and Viread.The......

Gilead to offer multiple AIDS drug licences

 US-based Gilead Sciences is scouting for partners to issue multiple 'manufacturing licences' for its AIDS drug, Tenofovir, in India and 97 other countries including those in Africa, the Caribbeans......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2024 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances